Search research articles
Contact Us
Filters
Showing results (251-260 of 293) with videos related to
Page
of 30
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancer
Tomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Methods
|
December 22, 2022
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration
Min Jae Song, Russ Quinn, Eric Nguyen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 17, 2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
Elena M Kaftanovskaya, Hooi Hooi Ng, Mariluz Soula, et al.
Elife
|
December 20, 2017
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein
Ismael Al-Ramahi, Sai Srinivas Panapakkam Giridharan, Yu-Chi Chen, et al.
Cancer Cell
|
November 16, 2016
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N Kelly, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Nature Communications
|
December 16, 2021
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model
Ruchi Sharma, Aman George, Malika Nimmagadda, et al.
ALTEX
|
December 15, 2024
State of the science on assessing developmental neurotoxicity using new approach methods
Susan J Debad, Jason Aungst, Kelly Carstens, et al.
Assessment
|
June 26, 2020
Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical Sample
Fernando Gutiérrez, Anton Aluja, José Ruiz, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 293) with videos related to
Sort By:
Page
of 30
Cancer Chemotherapy and Pharmacology
|
October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancer
Tomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Methods
|
December 22, 2022
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration
Min Jae Song, Russ Quinn, Eric Nguyen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 17, 2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
Elena M Kaftanovskaya, Hooi Hooi Ng, Mariluz Soula, et al.
Elife
|
December 20, 2017
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein
Ismael Al-Ramahi, Sai Srinivas Panapakkam Giridharan, Yu-Chi Chen, et al.
Cancer Cell
|
November 16, 2016
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N Kelly, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Nature Communications
|
December 16, 2021
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model
Ruchi Sharma, Aman George, Malika Nimmagadda, et al.
ALTEX
|
December 15, 2024
State of the science on assessing developmental neurotoxicity using new approach methods
Susan J Debad, Jason Aungst, Kelly Carstens, et al.
Assessment
|
June 26, 2020
Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical Sample
Fernando Gutiérrez, Anton Aluja, José Ruiz, et al.
Page
of 30